Literature DB >> 12227334

Theoretical considerations regarding the study "Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans".

Siiri Veromann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12227334      PMCID: PMC379206          DOI: 10.1086/342207

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  4 in total

1.  The appearance of alpha-crystallin in relation to cell cycle phase in the embryonic mouse lens.

Authors:  J Zwaan
Journal:  Dev Biol       Date:  1983-03       Impact factor: 3.582

2.  Short-range order of crystallin proteins accounts for eye lens transparency.

Authors:  M Delaye; A Tardieu
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

3.  Cataract development in 12-month-old rats fed a 25% galactose diet and its relation to osmotic stress and oxidative damage.

Authors:  Y Ohta; T Yamasaki; T Niwa; H Goto; Y Majima; I Ishiguro
Journal:  Ophthalmic Res       Date:  1999       Impact factor: 2.892

4.  Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans.

Authors:  V Berry; P Francis; M A Reddy; D Collyer; E Vithana; I MacKay; G Dawson; A H Carey; A Moore; S S Bhattacharya; R A Quinlan
Journal:  Am J Hum Genet       Date:  2001-09-27       Impact factor: 11.025

  4 in total
  2 in total

1.  A new locus for autosomal dominant posterior polar cataract in Moroccan Jews maps to chromosome 14q22-23.

Authors:  E Pras; O Mahler; V Kumar; M Frydman; N Gefen; E Pras; J F Hejtmancik
Journal:  J Med Genet       Date:  2006-10       Impact factor: 6.318

2.  Characterization of a novel mutation in the CRYBB2 gene associated with autosomal dominant congenital posterior subcapsular cataract in a Chinese family.

Authors:  Ke Yao; Jinyu Li; Chongfei Jin; Wei Wang; Yanan Zhu; Xingchao Shentu; Qiwei Wang
Journal:  Mol Vis       Date:  2011-01-13       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.